Skip to main content
Premium Trial:

Request an Annual Quote

Memorial Sloan-Kettering Receives OK from NY State to Use Sequenom's MassArray

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Memorial Sloan-Kettering Cancer Center has received what it believes is the first approval from the New York State Department of Health to use Sequenom's MassArray Compact 384 system for diagnosing gene mutations in patients.

The hospital will use the instrument to look for mutations in EGFR, KRAS, and BRAF in biopsy samples in patients with lung, colorectal, and thyroid cancers, as well as melanoma. The platform will also allow researchers at MSKCC to investigate mutations in lesser known genes and enroll patients in clinical trials for new, experimental targeted drugs.

Marc Ladanyi, chief of the Molecular Diagnostics Service and director of the Diagnostic Molecular Pathology Laboratory at MSKCC, led the team that developed the protocols and validated the Sequenom platform for clinical applications.

Ladanyi could not be reached for comment, but in MSKCC's newsletter, he said, "To our knowledge, we are the only hospital to have New York State approval to use the technology for this purpose."

At publication time, the NYS Department of Health had not confirmed that statement for GenomeWeb Daily News.

Last month, Sequenom launched the next iteration of the MassArray platform, called MassArray Analyzer 4.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.